Sugi Predict

Sugi Predict / Targets / WDR48

WDR48

WD repeat-containing protein 48 · Q8TAF3 · WDR48 on Sugi Atlas →

12,465 patent compounds predicted against WDR48, 6,128 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL786104 SCHEMBL786104 0.62 15/20
SCHEMBL786218 SCHEMBL786218 0.55 15/20
SCHEMBL786367 SCHEMBL786367 0.55 15/20
SCHEMBL3251693 SCHEMBL3251693 0.68 14/20
SCHEMBL786256 SCHEMBL786256 0.64 14/20
SCHEMBL786464 SCHEMBL786464 0.64 14/20
SCHEMBL786568 SCHEMBL786568 0.62 14/20
SCHEMBL785772 SCHEMBL785772 0.61 14/20
SCHEMBL786583 SCHEMBL786583 0.60 14/20
SCHEMBL801853 SCHEMBL801853 0.60 14/20
SCHEMBL786508 SCHEMBL786508 0.58 14/20
SCHEMBL786182 SCHEMBL786182 0.57 14/20
SCHEMBL786812 SCHEMBL786812 0.57 14/20
SCHEMBL785641 SCHEMBL785641 0.56 14/20
SCHEMBL786042 SCHEMBL786042 0.56 14/20
SCHEMBL786131 SCHEMBL786131 0.56 14/20
SCHEMBL805525 SCHEMBL805525 0.56 14/20
SCHEMBL786157 SCHEMBL786157 0.53 14/20
SCHEMBL786138 SCHEMBL786138 0.52 14/20
SCHEMBL3109481 SCHEMBL3109481 0.67 13/20

Clinical trials — most relevant to WDR48 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study PHASE3COMPLETED
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions nanCOMPLETED
MEHMO Natural History and Biomarkers nanRECRUITING
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
The Phenotyping and Genotyping of Taiwanese Patients With Obstructive Sleep Apnea nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Child Development and Genetic Biomarkers(II): Gene Verification and Data Integration nanUNKNOWN
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Study of a Candidate Gene Involved in Goldenhar Syndrome. nanCOMPLETED
Better Delineation of DDX3X Related Phenotype and Epigenetic Signature. nanUNKNOWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
A Retrospective and Prospective Natural History Study of Patients With WHIM Syndrome nanWITHDRAWN
Molecular Diagnosis of Syndromic or Isolated Severe Intellectual Disability Using Whole Exome Sequencing : a Pilot Study nanCOMPLETED
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Whole Genome Scan of Extended Families With Familial Vocal Cord Paralysis nanCOMPLETED
Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity. nanRECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Exploring Novel Biomarkers of ICU-AW in Mechanically Ventilated Children at the Molecular Level nanENROLLING_BY_INVITATION
Impact of Elastin Mediated Vascular Stiffness on End Organs nanCOMPLETED
iPSC Neurons From Adult Survivors of Childhood Cancer Who Have Persistent Vincristine-Induced Neuropathy nanCOMPLETED
Identification of the Genetic Causes of Rare Diseases With Negative Exome Findings nanUNKNOWN
Application of Linkage Analysis in the Identification of Novel Hereditary Factors in Familial Aneurysms nanACTIVE_NOT_RECRUITING
Use of miRNAs in Growth Hormone Deficiency (GHD) nanUNKNOWN
The Belgian Genome Resource to Resolve Rare Diseases nanCOMPLETED
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis nanWITHDRAWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a WDR48 binder may also engage these)

ProteinNameSimilarity
Q5RAW8 — 1.000 Q5RAW8 →
Q5F3K4 — 1.000 Q5F3K4 →
Q32PG3 — 1.000 Q32PG3 →
Q8BH57 — 1.000 Q8BH57 →
Q4R2Z6 — 1.000 Q4R2Z6 →
Q6PFM9 — 1.000 Q6PFM9 →
Q05B17 — 0.999 Q05B17 →
B3MET8 — 0.997 B3MET8 →
B4J8H6 — 0.997 B4J8H6 →
Q16MY0 — 0.997 Q16MY0 →
B0X2V9 — 0.997 B0X2V9 →
Q1LZ08 — 0.996 Q1LZ08 →
B4MFM2 — 0.995 B4MFM2 →
B4P7H8 — 0.995 B4P7H8 →
B4QB64 — 0.994 B4QB64 →
Q28YY2 — 0.993 Q28YY2 →
B4KRQ4 — 0.993 B4KRQ4 →
Q20059 — 0.992 Q20059 →
A8Q2R5 — 0.992 A8Q2R5 →
B4GIJ0 — 0.991 B4GIJ0 →
B3NSK1 — 0.989 B3NSK1 →
O00423 — 0.988 O00423 →
A6N6J5 — 0.988 A6N6J5 →
Q6S7B0 — 0.988 Q6S7B0 →
B4HND9 — 0.987 B4HND9 →
Q4V7Z1 — 0.986 Q4V7Z1 →
Q6DIP5 — 0.986 Q6DIP5 →
Q8BND3 — 0.986 Q8BND3 →
Q8UUP2 — 0.986 Q8UUP2 →
Q6PJI9 — 0.986 Q6PJI9 →